Latest posts by Lawrence F Muscarella PhD (see all)
- Are Enzymatic Detergents the Primary Cause of The Inflammatory Eye Reaction Called TASS? A recently published article investigates risk factors for TASS. - March 31, 2018
- Guidance to Prevent Other Flexible Endoscopes From Transmitting Superbug Infections. A new practice is discussed to reduce the risk of multidrug-resistant bacterial infections. - March 26, 2018
- FDA Warns Duodenoscope Manufacturers for Not Completing Ordered Surveillance Studies - March 15, 2018
“Discussions in Infection Control” is the most replete, and Google’s highest-ranking, infection-control blog in the world. Test it – search for any related topics, and note the high ranking of this blog’s URL” EndoscopeReprocessing.com
— For example, the search engine Bing ranks this blog #1 (visit: Bing.com) when using the search terms “endoscope reprocessing.”
— Or, the search engine Google ranks this blog #1 (visit: Google.com) when using the search terms “Greenville Memorial outbreak.”
More examples of this blog’s high search-engine rankings are provided on this page.
This blog — founded, designed and written by Lawrence F Muscarella, PhD — provides manufacturers and companies with an efficient, targeted, unrivaled and unique platform to optimize the advertising of their infection-control and related products to the audience that is most likely to appreciate and benefit from their products.
Get the biggest bang for your advertising buck — advertise your product in the blog “Discussions in Infection Control.”
Discussions in Infection Control focuses on the control and prevention of healthcare-associated infections (“HAIs”); instrument reprocessing; risk management in the endoscopy suite; and both risk assessments and root cause analyses, among others topics.
This blog is the most comprehensive, read, and focused of its type in the world.
This blog necessarily assures that the company’s targeted advertisement will be seen by a targeted, educated audience, not wasted in the proverbial ether.
Contact Lawrence F Muscarella, PhD, with any questions at: Larry@LFM-HCS.com
No other infection-control and instrument reprocessing blog in the world is viewed by as many healthcare professionals.
The ads’ contracts are binding from month-to-month, or year-to-year, and the manufacturer’s advertisement(s) would be embedded into the text of this blog’s more than 100 articles and side bar.
The cost for non-exclusive advertising is:
— $300 per month (term: month to month), or $3000 (discounted), if the term is for one year, for the placement of your company’s ads into this blog’s articles.
[B.] The cost for exclusive advertising — that is, no other company’s advertisements would appear in this blog’s articles; the company would, in effect, own the blog’s advertising rights, and its company’s ad(s) would appear throughout this blog’s articles — is:
— $1200 per month (term: month to month; or, $14,400 (no discount), if the term is for one year, for the exclusive placement of your company’s ads into this blog’s articles.
- Contact Dr. Muscarella with any questions about placing an ad in “Discussions in Infection Control” by sending email to: